Abstract 1369: An Unrelenting Vasculopathy: Recurrent Stroke During Treatment of Meningovascular Neurosyphilis
Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)
DOI: 10.1161/svi270000_1369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von B. Saber und 2 weiteren Autor:innen.
Themen: Schlaganfall
Abstract (Originalsprache)
An Unrelenting Vasculopathy: Recurrent Stroke During Treatment of Meningovascular Neurosyphilis Introduction/Purpose: Meningovascular neurosyphilis is an uncommon cause of ischemic stroke associated with inflammatory intracranial arteriopathy. Although intravenous penicillin is the standard treatment, the early course of the associated cerebrovascular disease following treatment initiation is poorly characterized. We describe recurrent multifocal cerebral infarction during appropriate antimicrobial therapy. Materials/Methods: Clinical presentation, cerebrospinal fluid studies, serologic testing, neuroimaging, treatment, and hospital course were reviewed retrospectively.
Results
A 70-year-old immunocompetent man presented with four days of progressive cognitive decline and fluctuating encephalopathy. Brain magnetic resonance imaging demonstrated acute infarcts involving the right basal ganglia, posterior periventricular white matter, and mesial temporal lobe. Computed tomography angiography demonstrated multifocal intracranial disease, including segmental occlusions of the left M1 segment and basilar artery and severe bilateral posterior cerebral artery stenoses, without hemodynamically significant extracranial stenosis. The vascular findings were initially considered consistent with intracranial atherosclerotic disease; however, mesial temporal involvement and fluctuating encephalopathy raised concern for an alternative arteriopathy and prompted lumbar puncture.Cerebrospinal fluid analysis demonstrated lymphocytic pleocytosis (142 cells/μL) and elevated protein (188 mg/dL). Reactive serum rapid plasma reagin and cerebrospinal fluid fluorescent treponemal antibody absorption testing supported the diagnosis of meningovascular neurosyphilis, prompting initiation of intravenous penicillin G. Eight days later, worsening mentation prompted repeat neuroimaging, which demonstrated new multifocal acute infarcts within the left middle cerebral artery territory. Repeat vascular imaging demonstrated persistent multifocal intracranial occlusive disease. The development of infarcts in a previously unaffected vascular territory raised concern for ongoing syphilitic arteritis despite antimicrobial therapy. He completed the prescribed intravenous penicillin course with gradual cognitive improvement.
Conclusion
Recurrent ischemic stroke may occur early during appropriate treatment of meningovascular neurosyphilis, potentially reflecting ongoing vascular inflammation rather than antimicrobial failure. Neurologic deterioration during treatment should prompt immediate repeat neuroimaging and reassessment of the underlying arteriopathy. This case highlights an important management uncertainty when cerebrovascular injury continues after antimicrobial therapy has begun.
Zitieren
APA
Saber, B., Birney, M. J., & Malhotra, R. J. (2026). Abstract 1369: An Unrelenting Vasculopathy: Recurrent Stroke During Treatment of Meningovascular Neurosyphilis. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1369
Vancouver
Saber B, Birney MJ, Malhotra RJ. Abstract 1369: An Unrelenting Vasculopathy: Recurrent Stroke During Treatment of Meningovascular Neurosyphilis. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1369
BibTeX
@article{Saber2026,
author = {Saber, B. and Birney, M. J. and Malhotra, R. J.},
title = {Abstract 1369: An Unrelenting Vasculopathy: Recurrent Stroke During Treatment of Meningovascular Neurosyphilis},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
volume = {6},
number = {Suppl_1},
doi = {10.1161/svi270000_1369}
}
EUVIMED